BioMonde Preparations Limited Report issue

For profit Phase 2
Founded: Ballasalla Isle of Man (1997)
Status: Left NME R&D (2015)

Organization Overview

First Clinical Trial
2005
NCT00225537
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2005

Timeline

NOW
  • Now